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Objective: To study the value of serum OPN levels in patients with acute cerebral
hemorrhage for assessment of neurological impairment.
Methods: A total of 48 patients with cerebral hemorrhage admitted to the Emergency
Department of our hospital from April 2014 to August 2015 were selected as the cerebral
hemorrhage group, and 50 cases who took health examination were selected as the control
group. Then, their clinical data were collected and the contents of OPN, S-100b, NSE,
SOD, T-AOC and MDA were detected.
Results: The contents of serum OPN [(24.52 ± 2.85) vs. (10.38 ± 1.25) pg/mL], S-100b
[(1.77 ± 0.20) vs. (0.59 ± 0.07) pg/mL] and NSE [(24.52 ± 2.85) vs. (10.38 ± 1.25) pg/mL]
in the cerebral hemorrhage group were signiﬁcantly higher than those of the control group,
while its SOD [(42.31 ± 5.45) vs. (67.65 ± 7.26) IU/mL] and T-AOC [(12.16 ± 1.42) vs.
(20.35 ± 2.35) IU/mL] were all distinctly lower than those of the control group. The greater
the amount of hemorrhage was, the more the contents of OPN [(5.75 ± 0.67) vs.
(7.92 ± 0.91) vs. (10.36 ± 1.16) ng/mL], S-100b [(1.03 ± 0.12) vs. (1.79 ± 0.20) vs.
(2.85 ± 0.30) pg/mL], NSE [(17.86 ± 2.14) vs. (23.94 ± 2.61) vs. (30.14 ± 3.48) pg/mL],
MDA [(4.03 ± 0.51) vs. (6.18 ± 0.81) vs. (9.59 ± 1.05) nmol/mL] were and the less the
contents of SOD [(52.44 ± 5.94) vs. (41.39 ± 5.26) vs. (25.52 ± 3.12) IU/mL] and T-AOC
[(16.59 ± 1.83) vs. (13.04 ± 1.63) vs. (8.39 ± 0.92) IU/mL] became. The contents of serum
OPN [(13.23 ± 1.63) vs. (6.95 ± 0.81) ng/mL], S-100b [(3.24 ± 0.52) vs. (0.91 ± 0.10) pg/
mL], NSE [(41.32 ± 5.14) vs. (16.61 ± 1.89) pg/mL] and MDA [(11.18 ± 1.26) vs.
(4.28 ± 0.54) nmol/mL] in patients with early deterioration were obviously higher than
those in patients without early deterioration, while their SOD [(15.25 ± 1.79) vs.
(40.59 ± 5.33) IU/mL] and T-AOC [(5.25 ± 0.77) vs. (16.25 ± 1.92) IU/mL] contents were
all evidently lower. The content of serumOPNwas positively associated with S-100b, NSE
and MDA, but negatively correlated with SOD and T-AOC.
Conclusions: The level of serum OPN in patients with acute cerebral hemorrhage
increased signiﬁcantly. The level of serum OPN could estimate the bleeding volume and
the severity of nerve function impairment for patients with acute cerebral hemorrhage.1. Introduction
In recent years, the incidence rate of stroke in our country is
rising constantly and exceeds cardiovascular disease, which hasbecome a leading cause for death and disability. Stroke was
divided into cerebral ischemic stroke and hemorrhagic stroke.
Although the incidence rate of cerebral ischemic stroke is rela-
tively high, hemorrhagic stroke causes more dangers and injuries
the nerve functions rapidly which harms patients greatly[1,2].
After cerebral hemorrhage, symptoms such as headache,
dizziness, vomit and so on would appear and then develop to
limbs dysfunction, unconsciousness quickly. In clinical
practice, the establishment of therapeutic regimen relies on the
accurate judgment of the disease[3,4]. However, most cerebral
hemorrhage patients remain in a coma when they are treated,
and they will stay in a coma for a period of time after they
receive evacuation of hematoma, which makes it difﬁcult torticle under the CC BY-NC-ND license (http://
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nerve function impairment correctly by routine neurological
function evaluation method[5,6].
The pathophysiological procedure of acute cerebral hem-
orrhage is very complicated. Intracranial hematoma can not
only cause mechanical press and damage the brain tissue, but
also affect the function of neurons simultaneously by multiple
humoral factors such as inﬂammation and oxidative stress[7,8].
In the development of cerebral hemorrhage, changes of the
above humoral factors will lead to changes of the contents of
multiple molecular in serum. Changes of the disease can be
evaluated by detecting the contents of the corresponding
molecular in serum. Osteopontin (OPN) is a kind of
secretory extracellular matrix protein participating in the
regulation processes such as immunological and
inﬂammatory reaction, atherosclerotic plaque formation etc.
There were researches reporting that the content of serum
OPN in patients with cerebrovascular diseases, such as
cerebral infarction and myocardial infarction, increased
signiﬁcantly and matched with the severity of the disease[9,10].
Nevertheless, researches whether OPN has participated in the
occurrence and development of acute cerebral hemorrhage or
not have not been reported. In the following study, we
investigate the value of serum OPN levels in patients with
acute cerebral hemorrhage for assessment of nerve function
impairment.
2. Materials and methods
2.1. Study subjects
A prospective study was conducted. All study subjects were
selected in accordance with the following criteria and grouped
into the cerebral hemorrhage group and control group. The study
was approved by the Theory Committee of the hospital and all
subjects signed an informed consent. The inclusion criteria of
subjects in the cerebral hemorrhage group were described as
follows. Patients who were treated in the Emergency Depart-
ment of our hospital from April 2012 to August 2015, met the
diagnosis standards of cerebral hemorrhage made by the Fourth
National Cerebrovascular Diseases Conference, admitted to
hospital within 12 h after the onset of the disease and diagnosed
with cerebral hemorrhage by CT examination were included in
the cerebral hemorrhage group, while patients with tumor,
trauma, vascular malformation caused cerebral hemorrhage,
subarachnoid hemorrhage, intracranial tumor, history of anti-
platelet or anticoagulant drugs and accompanied with heart
failure or liver and renal diseases were excluded. Subjects of the
control group were healthy people whose gender, age, BMI and
were matched with those of patients in the cerebral hemorrhage
group. They were all from the Physical Examination Center of
our hospital and proved to be without cranial vascular diseases
and liver and kidney dysfunction.
2.2. Clinical materials collection
According to their medical records or examination reports,
the clinical materials of those study subjects were collected and
typed into computers. The concrete materials included their
gender, age, height, weight, blood pressure, body temperatureand number of combined hypertension, diabetes and hyperlip-
idemia. Patients with cerebral hemorrhage would be given a CT
examination after admission and the hematoma volume would
be tested and calculated in accordance with Tada formula: he-
matoma volume = p × length (cm) × width (cm) × height (cm)/
6. It could be deﬁned as mild hemorrhage when the hematoma
volume was less than 20 mL, moderate hemorrhage when it was
20–40 mL and severe hemorrhage when it exceeded 40 mL.
Patients were all received NIHSS scores when admitted to
hospital and 2 days after admission. Patients with an increase of
four or more sores within 2 days were diagnosed with early
neurological deterioration.
2.3. Serum samples collection and indexes detection
As soon as cerebral hemorrhage patients admitted to hospital,
10 mL peripheral venous blood of them were collected imme-
diately, while the same amount of peripheral venous blood of
subjects in the control group were collected during their physical
examination, placed still for 10–15 min and centrifuged with a
centrifugal force of 3000 g for 10 min to gather the upper serum.
ELISA kits were used to determine the contents of OPN, S-100b
protein, neurone speciﬁc enolase (NSE), superoxide dismutase
(SOD), total antioxidant capacity (T-AOC) and malonaldehyde
(MDA).
2.4. Statistical methods
Version SPSS 19.0 of the software was applied to record and
analyze data. Measurement data were presented as mean ± SD.
Analysis between groups were determined by t-test. Enumera-
tion data were expressed by frequency and analyzed by Chi-
square test. The collection between two variables was tested by
Pearson's correlation analysis. Differences were statistical sig-
niﬁcant when P < 0.05.
3. Results
3.1. Clinical data of subjects of the two groups
In the 48 cases of the cerebral hemorrhage group, there
were 30 males and 18 females with ages of (52.4 ± 6.4) years,
BMI of (22.1 ± 2.5) kg/m2, and 27 cased were combined with
hypertension, 11 with diabetes and 13 with hyperlipidemia. In
the control group, there were 33 males and 17 females with
ages of (53.1 ± 5.9) years and BMI (22.5 ± 2.3) kg/m2, and 9
cases were combined with hypertension, 4 with diabetes and
11 with hyperlipidemia. The results of statistic analysis showed
no differences in gender, age, BMI and the combined hyper-
lipidemia between the two groups, while the combined hy-
pertension and diabetes cases of the cerebral hemorrhage group
were obviously higher than those of the control group. The
serum OPN [(8.14 ± 0.95) vs. (3.37 ± 0.42) ng/mL], S-100b
[(1.77 ± 0.20) vs. (0.59 ± 0.07) pg/mL] and NSE
[(24.52 ± 2.85) vs. (10.38 ± 1.25) pg/mL] of the cerebral
hemorrhage group were all signiﬁcantly higher than those of
the control group, while its SOD [(42.31 ± 5.45) vs.
(67.65 ± 7.26) IU/mL] and T-AOC [(12.16 ± 1.42) vs.
(20.35 ± 2.35) IU/mL] were evidently lower than those of the
control group (Table 1).
Table 1
Clinical data of subjects of the two groups.
Parameter Cerebral hemorrhage






30/18 33/17 > 0.05
Age (year) 52.4 ± 6.4 53.1 ± 5.9 > 0.05
BMI (kg/m2) 22.1 ± 2.5 22.5 ± 2.3 > 0.05
Hypertension 27 (56.25%) 9 (18%) < 0.05
Diabetes 11 (22.92%) 4 (8%) < 0.05
Hyperlipidemia 13 (27.08%) 11 (22%) > 0.05
OPN (ng/mL) 8.14 ± 0.95 3.37 ± 0.42 < 0.05
S-100b (pg/mL) 1.77 ± 0.20 0.59 ± 0.07 < 0.05
NSE (pg/mL) 24.52 ± 2.85 10.38 ± 1.25 < 0.05
SOD (IU/mL) 42.31 ± 5.45 67.65 ± 7.26 < 0.05
T-AOC (IU/mL) 12.16 ± 1.42 20.35 ± 2.35 < 0.05
MDA (nmol/mL) 6.33 ± 0.69 2.14 ± 0.28 < 0.05
BMI: Body mass index; S-100b: S-100b protein.
Table 3







OPN (ng/mL) 13.23 ± 1.63 6.95 ± 0.81 < 0.05
S-100b (pg/mL) 3.24 ± 0.52 0.91 ± 0.10 < 0.05
NSE (pg/mL) 41.32 ± 5.14 16.61 ± 1.89 < 0.05
SOD (IU/mL) 15.25 ± 1.79 40.59 ± 5.33 < 0.05
T-AOC (IU/mL) 5.25 ± 0.77 16.25 ± 1.92 < 0.05
MDA (nmol/mL) 11.18 ± 1.26 4.28 ± 0.54 < 0.05
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patients with different bleeding volume
The contents of OPN, S-100b, NSE, SOD, T-AOC and MDA
of cerebral hemorrhage patients with different bleeding volume
were different. The greater the amount of bleeding volume was,
the more the contents of OPN [(5.75 ± 0.67) vs. (7.92 ± 0.91) vs.
(10.36 ± 1.16) ng/mL], S-100b [(1.03 ± 0.12) vs. (1.79 ± 0.20)
vs. (2.85 ± 0.30) pg/mL], NSE [(17.86 ± 2.14) vs. (23.94 ± 2.61)
vs. (30.14 ± 3.48) pg/mL] and MDA [(4.03 ± 0.51) vs.
(6.18 ± 0.81) vs. (9.59 ± 1.05) nmol/mL] were and the less the
contents of SOD [(52.44 ± 5.94) vs. (41.39 ± 5.26) vs.
(25.52 ± 3.12) IU/mL] and T-AOC [(16.59 ± 1.83) vs.
(13.04 ± 1.63) vs. (8.39 ± 0.92) IU/mL] (Table 2).
3.3. Serum biochemical indexes of cerebral hemorrhage
patients with different neurological function
The contents of OPN, S-100b, NSE, SOD, T-AOC and MDA
of cerebral hemorrhage patients with different neurological
function were different. The contents of serum OPN
[(13.23 ± 1.63) vs. (6.95 ± 0.81) ng/mL], S-100b [(3.24 ± 0.52)
vs. (0.91 ± 0.10) pg/mL], NSE [(41.32 ± 5.14) vs.
(16.61 ± 1.89) pg/mL] and MDA [(11.18 ± 1.26) vs.
(4.28 ± 0.54) nmol/mL] in patients with early deterioration were
obviously higher than those in patients without early deteriora-
tion, while their SOD [(15.25 ± 1.79) vs. (40.59 ± 5.33) IU/mL]
and T-AOC [(5.25 ± 0.77) vs. (16.25 ± 1.92) IU/mL] contents
were all evidently lower (Table 3).Table 2









OPN (ng/mL) 5.75 ± 0.67 7.92 ± 0.91 10.36 ± 1.16 < 0.05
S-100b (pg/mL) 1.03 ± 0.12 1.79 ± 0.20 2.85 ± 0.30 < 0.05
NSE (pg/mL) 17.86 ± 2.14 23.94 ± 2.61 30.14 ± 3.48 < 0.05
SOD (IU/mL) 52.44 ± 5.94 41.39 ± 5.26 25.52 ± 3.12 < 0.05
T-AOC (IU/mL) 16.59 ± 1.83 13.04 ± 1.63 8.39 ± 0.92 < 0.05
MDA (nmol/mL) 4.03 ± 0.51 6.18 ± 0.81 9.59 ± 1.05 < 0.053.4. The correlation between serum biochemical indexes
The content of OPN was positively correlated with S-100b,
NSE and MDA, and the r values were 0.771, 0.715 and 0.664,
respectively. Besides, it was negatively correlated with SOD and
T-AOC, and the r values were −0.689 and −0.735, respectively.
4. Discussion
Acute cerebral hemorrhage is a serious emergency with poor
prognosis. Its clinical symptoms develop rapidly and the
neurological functions of patients deteriorate in a short period.
Patients will then suffer from unconsciousness, hemiplegic
limbs, which raise difﬁculties for the evaluation of the disease
and the design of a treatment plan[11]. In clinical practices,
evacuation of hematoma is the preferred way to treat cerebral
hemorrhage, but the speciﬁc treatment plan depends on the
accurate evaluation of the disease[12,13]. At present, evaluation
of the conditions and neurological function of acute cerebral
hemorrhage patients have reached no common understanding.
There are many researches reporting the value of different
serum molecular for the evaluation of the conditions of
patients with cerebral hemorrhage[14–16].
Studied subjects collected for this study included acute ce-
rebral hemorrhage patients and healthy people. In the cerebral
hemorrhage group, the ratio of cases combined with hyperten-
sion and diabetes was signiﬁcantly higher than that of the control
group, which agreed with previous researches made by other
domestic and overseas scholars. That was to say hypertension
and diabetes were dangerous factors of acute cerebral hemor-
rhage, which indicated that the levels of blood pressure and
blood glucose of patients should be controlled strictly so as to
avoid further deterioration in the treatment process of the dis-
ease. It was found in the analysis of the content of OPN in ce-
rebral hemorrhage patients and healthy people that the OPN
content of acute cerebral hemorrhage patients increased obvi-
ously. OPN is a kind of phosphoglycoprotein which was ﬁrstly
found in the bones. It plays a regulatory role in the process of
bone formation and bone calciﬁcation. With the deep recogni-
tion of OPN in recent years, more and more researches claim
that OPN participates in the regulation processes such as
immunological and inﬂammatory reaction, atherosclerotic pla-
que formation and so on and it is also connected with the inci-
dence of cerebrovascular diseases, such as myocardial infarction
and cerebral infarction[17–19]. According to the analysis of the
OPN content in this study, the increase of the OPN content
was related to the incidence of acute cerebral hemorrhage.
There are researches reporting that OPN can serve as a kind
of soluble cytokine to participate in the processes of the
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gregation of multiple inﬂammatory cells in vascular endothelial
cell, smooth muscle cell and macrophage, so as to produce
various inﬂammatory cytokines and accelerate the formation of
foam cells and atherosclerosis[20–22]. Moreover, OPN can also
serve as extracellular matrix proteins, which would increase
the risks of the plaque rupture by causing the reconstruction of
the components of atherosclerotic plaques and changes of the
nature of the plaque[23,24]. In order to conﬁrm the relationship
between OPN content and the development of acute cerebral
hemorrhage, we analyzed the changes of OPN contents in
acute cerebral hemorrhage patients with different bleeding
volume and degradation extent. The results showed that the
more the bleeding volume were, the more seriously the
neurological functions deteriorated and the more signiﬁcantly
the OPN content increased, which illustrated that the increase
of the OPN content was closely related to the severity and
growing trend of the disease.
The physiological and pathological process of acute cerebral
hemorrhage is very complicated. Intracranial hematoma could
damage neurons by various humoral factors such as inﬂamma-
tion and oxidative stress[25,26]. S100b protein is a kind of acidic
binding protein existing in glial cells. NSE is a type of
enzymes existing in many neuroendocrine cells and
participating in the energy metabolism of cells. When nerve
cell and neural glia cells were injured by the stress of
intracranial hematoma, a large amount of S100b and NSE
were released and entered cerebrospinal ﬂuid and then
accessed to blood circulation through blood–brain barrier. To
a certain degree, the impairment severity of neurological
function could be determined by testing the contents of serum
S100b and NSE[27–29]. Oxidative stress reaction is an important
mechanism of brain tissue injury post cerebral hemorrhage.
Many oxygen radicals were produced under the effect of
mechanical press and regional hypoxia, which, on the one
hand, caused the peroxidation of tissue structure and the
creation of MDA, and on the other hand, the antioxidant
substance SOD was consumed constantly and the total
antioxidant capacity was therefore weakened[30–32]. After
analyzing the contents of the above nerve-injured molecules
and oxidative stress molecules, it was found that the contents of
serum NSE, S100b and MDA of patients with acute cerebral
infarction increased signiﬁcantly and their SOD and T-AOC
contents decreased distinctly. Besides, they were all associated
with the content of serum OPN. It could be concluded that the
level of OPN has good consistency with the neurological
impairment severity and oxidative stress level.
To sum up, the level of serum OPN in patients with acute
cerebral hemorrhage increased signiﬁcantly; the level of serum
OPN could estimate the bleeding volume, outcome and the
severity of nerve function impairment for patients with acute
cerebral hemorrhage.
Conﬂict of interest statement
The authors report no conﬂict of interest.
References
[1] Xie AM, Luo L, Ding YJ, Li GJ. Ischemic and hemorrhagic
moyamoya disease in adults: CT ﬁndings. Int J Clin Exp Med
2015; 8(11): 21351-7.[2] Pasquini M, Benedictus MR, Boulouis G, Rossi C, Dequatre-
Ponchelle N, Cordonnier C. Incident cerebral microbleeds in a
cohort of intracerebral hemorrhage. Stroke 2016; 47(3): 689-94.
[3] Dandapat S, Robinson JG. Guidelines for management of hyper-
lipidemia: implications for treatment of patients with stroke sec-
ondary to atherosclerotic disease. Curr Neurol Neurosci Rep 2016;
16(3): 24.
[4] Takumi I, Mishina M, Kominami S, Mizunari T, Kobayashi S,
Teramoto A, et al. Ambient temperature change increases in stroke
onset: analyses based on the Japanese regional metrological mea-
surements. J Nippon Med Sch 2015; 82(6): 281-6.
[5] Shoeibi A, Salehi M, Thrift AG, Kapral MK, Farzadfard MT,
Azarpazhooh A, et al. One-year case fatality rate following stroke
in the Mashhad Stroke Incidence Study: a population-based study
of stroke in Iran. Int J Stroke 2015; 10(Suppl. A100): 96-102.
[6] Arab AF, Ahmed ME, Ahmed AE, Hussein MA, Khankan AA,
Alokaili RN. Accuracy of Canadian CT head rule in predicting
positive ﬁndings on CT of the head of patients after mild head
injury in a large trauma centre in Saudi Arabia. Neuroradiol J
2015; 28(6): 591-7.
[7] Wadas TM. Emerging inﬂammatory biomarkers with acute stroke.
Crit Care Nurs Clin North Am 2009; 21(4): 493-505.
[8] Kumar A, Kumar P, Kathuria P, Misra S, Pandit AK,
Chakravarty K, et al. Genetics of ischemic stroke: an Indian sce-
nario. Neurol India 2016; 64(1): 29-37.
[9] Kurata M, Okura T, Kumon Y, Tagawa M, Watanabe H,
Nakahara T, et al. Plasma thrombin-cleaved osteopontin elevation
after carotid artery stenting in symptomatic ischemic stroke pa-
tients. Hypertens Res 2012; 35(2): 207-12.
[10] Okyay K, Tavil Y, Sahinarslan A, Tacoy G, Turfan M, Sen N, et al.
Plasma osteopontin levels in prediction of prognosis in acute
myocardial infarction. Acta Cardiol 2011; 66(2): 197-202.
[11] Gathier CS, Dankbaar JW, van der Jagt M, Verweij BH,
Oldenbeuving AW, Rinkel GJ, et al. Effects of induced hyperten-
sion on cerebral perfusion in delayed cerebral ischemia after
aneurysmal subarachnoid hemorrhage: a randomized clinical trial.
Stroke 2015; 46(11): 3277-81.
[12] Saxena A, Anderson CS, Wang X, Sato S, Arima H, Chan E, et al.
Prognostic signiﬁcance of hyperglycemia in acute intracerebral
hemorrhage: the INTERACT2 study. Stroke 2016; 47(3): 682-8.
[13] Feng Y, He J, Liu B, Yang L, Wang Y. Endoscope-assisted
keyhole technique for hypertensive cerebral hemorrhage in elderly
patients: a randomized controlled study in 184 patients. Turk
Neurosurg 2016; 26(1): 84-9.
[14] Chang CZ, Wu SC, Kwan AL. A purine antimetabolite attenuates
toll-like receptor-2, -4, and subarachnoid hemorrhage-induced
brain apoptosis. J Surg Res 2015; 199(2): 676-87.
[15] Hu Q, Liu A, Huang M, Cheng L, Kang H, Xu F, et al. Lower
serum uric acid levels in cerebral amyloid angiopathy: a pilot
study. Neurol Sci 2014; 35(7): 1035-9.
[16] Kitchens WH, Adams AB, Hughes CB, Subramanian RM. Diag-
nostic challenges in the evaluation of hepatic grafts from donors
with HELLP syndrome: case report and review of the literature.
Transplant Proc 2011; 43(10): 4010-2.
[17] Higgins CL, Isbilir S, Basto P, Chen IY, Vaduganathan M,
Vaduganathan P, et al. Distribution of alkaline phosphatase,
osteopontin, RANK ligand and osteoprotegerin in calciﬁed human
carotid atheroma. Protein J 2015; 34(5): 315-28.
[18] Gliem M, Krammes K, Liaw L, van Rooijen N, Hartung HP,
Jander S. Macrophage-derived osteopontin induces reactive astro-
cyte polarization and promotes re-establishment of the blood brain
barrier after ischemic stroke. Glia 2015; 63(12): 2198-207.
[19] Bjerre M, Pedersen SH, Møgelvang R, Lindberg S, Jensen JS,
Galatius S, et al. High osteopontin levels predict long-term
outcome after STEMI and primary percutaneous coronary inter-
vention. Eur J Prev Cardiol 2013; 20(6): 922-9.
[20] Ju¨rets A, Le Bras M, Stafﬂer G, Stein G, Leitner L, Neuhofer A,
et al. Inhibition of cellular adhesion by immunological targeting of
osteopontin neoepitopes generated through matrix metal-
loproteinase and thrombin cleavage. PLoS One 2016; 11(2):
e0148333.
Jian-Ming Li, Cheng Zhang/Journal of Acute Disease 2016; 5(3): 222–226226[21] Wolak T. Osteopontin – a multi-modal marker and mediator in
atherosclerotic vascular disease. Atherosclerosis 2014; 236(2):
327-37.
[22] Genre F, Lo´pez-Mejías R, Miranda-Filloy JA, Ubilla B, Carnero-
Lo´pez B, Go´mez-Acebo I, et al. Correlation between two bio-
markers of atherosclerosis, osteopontin and angiopoietin-2, in non-
diabetic ankylosing spondylitis patients undergoing TNF-a antag-
onist therapy. Clin Exp Rheumatol 2014; 32(2): 231-6.
[23] Arcidiacono T, Mingione A, Macrina L, Pivari F, Soldati L,
Vezzoli G. Idiopathic calcium nephrolithiasis: a review of patho-
genic mechanisms in the light of genetic studies. Am J Nephrol
2014; 40(6): 499-506.
[24] Li Y, Xie Y, Cui D, Ma Y, Sui L, Zhu C, et al. Osteopontin promotes
invasion, migration and epithelial-mesenchymal transition of human
endometrial carcinoma cell HEC-1A through AKT and ERK1/2
signaling. Cell Physiol Biochem 2015; 37(4): 1503-12.
[25] Wu L, Chen G. Signaling pathway in cerebral vasospasm after
subarachnoid hemorrhage: news update. Acta Neurochir Suppl
2016; 121: 161-5.
[26] Ji C, Chen G. Signaling pathway in early brain injury after sub-
arachnoid hemorrhage: news update. Acta Neurochir Suppl 2016;
121: 123-6.
[27] Azurmendi L, Degos V, Tiberti N, Kapandji N, Sanchez-Peña P,
Sarrafzadeh A, et al. Neopterin plasma concentrations in patientswith aneurysmal subarachnoid hemorrhage: correlation with
infection and long-term outcome. J Neurosurg 2015: 1-13.
[28] Nguyen DN, Huyghens L, Wellens F, Schiettecatte J, Smitz J,
Vincent JL. Serum S100B protein could help to detect cerebral
complications associated with extracorporeal membrane oxygena-
tion (ECMO). Neurocrit Care 2014; 20(3): 367-74.
[29] Moritz S, Warnat J, Bele S, Graf BM, Woertgen C. The prognostic
value of NSE and S100B from serum and cerebrospinal ﬂuid in
patients with spontaneous subarachnoid hemorrhage. J Neurosurg
Anesthesiol 2010; 22(1): 21-31.
[30] Dai QD, Si JC, Xu ZH, Yang CH, Zhang JP. [The change of
inﬂammatory cytokines and products of oxidative stress in the
patients with acute cerebral hemorrhage and its clinical signiﬁ-
cance]. Chin J Clin (Electronic Edition) 2014; 8(3): 398-402.
Chinese.
[31] Caldas JP, Braghini CA, Mazzola TN, Vilela MM, Marba ST. Peri-
intraventricular hemorrhage and oxidative and inﬂammatory stress
markers in very-low birth weight newborns. J Pediatr (Rio J) 2015;
91(4): 373-9.
[32] Zhang ZY, Yang MF, Wang T, Li DW, Liu YL, Zhang JH, et al.
Cysteamine alleviates early brain injury via reducing oxidative
stress and apoptosis in a rat experimental subarachnoid hemorrhage
model. Cell Mol Neurobiol 2015; 35(4): 543-53.
